Paul Ryan joins SHINE Medical Technologies board of directors

Former House Speaker Paul Ryan has been appointed to the board of directors of Janesville, Wisconsin-based SHINE Medical Technologies.

Ryan was born and raised in Janesville, where SHINE is also currently building its medical isotope production facility, and he still owns a home there.

“I am excited to be joining SHINE’s board at this important time in the company’s development,” Ryan said in a prepared statement. “SHINE is uniquely equipped to create a reliable global supply of lifesaving medical isotopes, which would allow patients around the world to receive diagnosis and treatment when they need it most. Companies like SHINE play an important role in the delivery of cutting-edge health care and I will be able to help the company continue to grow.”

“Paul is a visionary with a wealth of experience and an expansive network that are welcome additions to SHINE’s board,” Greg Piefer, founder and CEO of SHINE, said in the same statement. “Paul will provide critical guidance to SHINE as we expand into domestic and international markets that require deep mastery of global policy, economics and leadership. His knowledge of domestic and international health care and energy policy will be an invaluable guide to us. We also are excited to be working with someone who cares about building great things in Janesville as deeply as we do.”

Ryan spent 20 years in the U.S. House of Representatives, serving as house speaker and running as the Republican party’s vice-presidential nominee in 2012.  

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.